Biotech | August 17, 2022
Merck and Orna Therapeutics collaborate to advance Orna’s nextgen RNA technology
Collaboration supports multiple discovery efforts, including vaccines
Collaboration supports multiple discovery efforts, including vaccines
Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery
Both companies have been selected for stand-by production by German government
The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
Four-year research collaboration combines Pfizer’s deep experience in global drug development, including programs utilizing messenger RNA (mRNA), lipid nanoparticles (LNP), and gene therapy, with Beam’s leadership in base editing and mRNA/LNP delivery technologies
Subscribe To Our Newsletter & Stay Updated
